Covered recipient · General Payments record
FILIX KENCANA
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$3,633.40
- Reported across 150 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $409.87 | 9 |
| Education | $26.70 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $133.79 | 1 |
| Acerta Pharma LLC | $66.59 | 1 |
| Gilead Sciences, Inc. | $64.02 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $57.76 | 2 |
| Dendreon Pharmaceuticals LLC | $30.34 | 1 |
| EISAI INC. | $26.70 | 2 |
| Tempus AI, Inc | $24.43 | 1 |
| ABBVIE INC. | $19.39 | 1 |
| E.R. Squibb & Sons, L.L.C. | $13.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.39 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104051368 | CMS |
| AstraZeneca Pharmaceuticals LP | $66.59 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105831227 | CMS |
| Dendreon Pharmaceuticals LLC | $30.34 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149318220 | CMS |
| E.R. Squibb & Sons, L.L.C. | $13.55 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101232375 | CMS |
| Eisai Inc. | $13.35 | 08/16/2024 | Education | Undisputed | 01/23/2026 | 1110745504 | CMS |
| Eisai Inc. | $13.35 | 11/14/2024 | Education | Undisputed | 01/23/2026 | 1110745506 | CMS |
| Gilead Sciences, Inc. | $64.02 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133799500 | CMS |
| JAZZ PHARMACEUTICALS INC. | $133.79 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150232487 | CMS |
| Novartis Pharmaceuticals Corporation | $20.03 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087069526 | CMS |
| Novartis Pharmaceuticals Corporation | $37.73 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087069534 | CMS |
| Tempus AI, Inc | $24.43 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150167490 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.